Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
about
The Adenosinergic System in Diabetic RetinopathyRole of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantCurrent trends in the monitoring and treatment of diabetic retinopathy in young adultsTherapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyShort Pulse Duration High-Power Laser Photocoagulation during Vitrectomy for Diabetic Retinopathy Reduces Postoperative InflammationER stress and apoptosis: a new mechanism for retinal cell death.Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?Leukocyte-mediated endothelial cell injury and death in the diabetic retinaFT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic RetinopathyAge-related alterations in retinal neurovascular and inflammatory transcriptsVascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetesLeukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathyCalcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetesOcular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic ratsSustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.Morphology and topography of retinal pericytes in the living mouse retina using in vivo adaptive optics imaging and ex vivo characterization.Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptidesThe role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.Current and future pharmacological intervention for diabetic retinopathy.Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Diabetic retinopathy: an updateWhole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory responseA randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay eye study.Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.Pharmacologic therapies for diabetic retinopathy and diabetic macular edemaRemodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edemaImaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopyNADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.Molecular Imaging of Retinal Endothelial Injury in Diabetic Animals.Role of inflammation in previously untreated macular edema with branch retinal vein occlusionThe multifactorial nature of retinal vascular diseaseLocalization of vascular adhesion protein-1 (VAP-1) in the human eye.The effect of lithospermic acid, an antioxidant, on development of diabetic retinopathy in spontaneously obese diabetic ratsIntraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema.Surface engineering of quantum dots for in vivo vascular imaging.Vitreous inflammatory factors in macular edema with central retinal vein occlusion.
P2860
Q26748944-4D2EDB8B-7E5B-4DC2-BF7E-1FC0EB39E83BQ26775853-E593A9DF-8B79-48AA-83A4-6FA5A00C2D51Q26863388-BEA7F501-BFA8-4DC1-94F9-FD32863AA9FCQ27021701-91B442C9-A202-4F6A-AA07-71948D6C9756Q27300854-B47A26D3-3265-4B5C-BDE0-52A3DA8AE549Q27690757-80A40E74-6840-4F31-8219-2421AF4E9BF1Q28066675-EE454D74-9A24-4380-A102-4003412E0A57Q28345653-2993868D-34E0-419B-B7ED-F5B1413EFA27Q28546854-C66A2E83-1642-4F9B-9ED5-C8FD8AFAD25EQ28570411-BE37478E-8434-46BD-AB6F-A4DA605F0C87Q28576300-3251851F-4B88-44F5-B5FF-B57DE46D5B58Q28576755-70C33F0A-1F00-469D-A1C6-3B0B22A0EE6FQ28584295-FD474F26-CBD4-4F37-A813-E195C8FA6CF7Q28730878-25C797B6-1F70-4E46-8C38-EA83FC199E58Q28817495-CDED203A-E458-4D91-83C5-8D9BFD334FC7Q30393975-C8F9484B-3E04-4BA8-A696-916C32F49AC3Q30560244-0376110B-A8A6-43FA-BA68-37F8C702F3CDQ30990845-2C887D6E-1F2C-4342-9AB5-C8A48BD48B6CQ31061150-CB9C9198-2A55-4D24-A07F-0BA3C0303576Q33216425-62A16DA2-2256-4AAB-B9B6-D92B604B8E0AQ33325652-C483C99D-794C-48BC-BC87-80CED31A4987Q33328784-5869385A-E1D2-42B8-BF27-0556C0915F84Q33343728-F60E6C3A-7074-4595-B75B-C658649C219EQ33355710-407D485B-7058-4214-B3D1-4E3529502323Q33392574-6AF5DDCB-3522-4E43-B21E-556FEDD79143Q33431322-D685F5ED-9A81-49A6-B327-F1063025969EQ33492340-3D524689-984B-4F37-8F4A-37D16FC7ACCCQ33556542-98D24C56-B2F9-49E0-BDD2-067EABBD775BQ33563100-A41BF1FE-E766-48F2-87FA-831C30D42BD4Q33571085-5F48C535-E005-4E7D-889C-0F6293B3EE46Q33632781-37116152-F07B-43A1-B825-131ED77195CEQ33641974-C1067179-5316-4196-8FDB-F615EF21873DQ33652612-8A49CEAC-1450-4395-A5EE-7CE70601BF71Q33656127-F72F4DDB-7EFE-40F9-862A-89744D0885D8Q33660130-33FC1265-FA36-479C-8EE0-B01000D8FD42Q33677290-738FBC09-ACD4-4546-82CD-67C807BC0A6EQ33721347-BAD0D10F-BBF1-409B-B747-ED35F6426BB6Q33771458-11342E54-2045-44F8-903E-9620203C4F4DQ33782729-1893EED5-CCF0-44CD-8B30-10ECFF9713E0Q33888116-AE2D3D55-B556-412B-9052-D25EBE2D8748
P2860
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@ast
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@en
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@nl
type
label
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@ast
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@en
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@nl
prefLabel
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@ast
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@en
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@nl
P2093
P2860
P3181
P356
P1476
Prevention of leukostasis and ...... adhesion molecule-1 inhibition
@en
P2093
A C Clermont
A P Adamis
K Miyamoto
L P Aiello
S E Bursell
P2860
P304
P3181
P356
10.1073/PNAS.96.19.10836
P407
P577
1999-09-14T00:00:00Z